TL;DR
This paper presents a novel approach to simultaneously treat a rare cardiac tumor (tricuspid valve papillary fibroelastoma) and lung cancer in an elderly patient using a single minimally invasive surgery. This case report and literature review suggest that this combined approach is safe and effective, potentially avoiding the risks associated with staged surgeries.
What Problem Does This Paper Address?
The paper addresses the challenge of managing elderly patients who present with both a cardiac tumor and lung cancer. While it's common for lung cancer patients to have co-existing heart conditions, the combination of a tricuspid valve papillary fibroelastoma (PFE) and lung cancer is particularly rare. The key question is whether to perform two separate surgeries (staged approach) or a single, combined surgery (concomitant approach). Staged surgeries can increase risks due to repeated anesthesia, potential ischemia/reperfusion injury, and delayed cancer treatment. Traditional concomitant surgeries often require median sternotomy, which carries its own set of risks, especially in elderly patients. This paper explores the feasibility and safety of a minimally invasive concomitant approach for this specific, rare dual diagnosis.
Methods
The authors describe a case where a 73-year-old male, initially being evaluated for a right lower lung nodule via video-assisted thoracic surgery (VATS), was found to have a tricuspid valve papillary fibroelastoma (PFE) during a transthoracic echocardiography (TTE). The surgical approach was a single right minithoracotomy. This allowed for the resection of both the PFE and the lung nodule. The cardiac PFE was removed from the tricuspid valve using an on-pump beating-heart technique, preserving the valve. The lung nodule was then resected using a standard VATS lobectomy with mediastinal lymph node dissection. The authors highlight that this single incision approach avoided median sternotomy and its associated risks.
Datasets
Not discussed in the paper. This is a case report and literature review, not a study involving large datasets for training or evaluation.
Key Insights and Ideas
- Minimally Invasive Concomitant Surgery is Feasible: The paper demonstrates that it's possible to successfully treat both a tricuspid valve PFE and lung cancer in a single, minimally invasive procedure using a right minithoracotomy.
- Avoiding Median Sternotomy: The chosen approach bypasses the need for median sternotomy, which is a significant advantage for elderly patients, reducing surgical trauma and recovery time.
- On-Pump Beating-Heart Technique for PFE: For cardiac tumor resection, the authors opted for an on-pump beating-heart technique rather than cardioplegic arrest and aortic cross-clamping, a choice influenced by the patient's advanced age.
- Importance of Early Detection and Intervention: The case underscores the value of thorough preoperative evaluation, as the PFE was incidentally discovered during the workup for lung cancer.
- Low Recurrence Rate: The patient showed no signs of recurrence for both the lung cancer and the PFE after 15 months of follow-up, suggesting the efficacy of the radical resection.
Key Results
- The patient underwent a successful concomitant minimally invasive surgery for both tricuspid valve PFE and right lower lung cancer.
- The surgery was uneventful, with a total duration of 3 hours and 30 minutes.
- Histopathology confirmed squamous cell carcinoma of the lung and papillary fibroelastoma of the tricuspid valve.
- The patient recovered uneventfully and was discharged 8 days post-operation.
- After 15 months of follow-up, there was no evidence of tumor recurrence for either the lung cancer or the PFE.
Limitations and Future Work
- Case Report Nature: This is a single case report, limiting the generalizability of the findings. Larger studies are needed to confirm the safety and efficacy of this approach across a broader patient population.
- Rarity of the Condition: The extreme rarity of concomitant tricuspid valve PFE and lung cancer makes it difficult to establish definitive treatment guidelines based on extensive evidence.
- Future Work: The authors suggest that after careful evaluation, concomitant minimally invasive radical resection of primary lung cancer after cardiac PFE removal is an acceptable and safe treatment strategy and should be performed as soon as possible. They advocate for this combined approach as a therapeutic option for such combined lesions. Further research into optimal patient selection and long-term outcomes for this combined surgical strategy is warranted.
Summary updated